The price of Bevacizumab 2022 generally ranges from 1,450 to 2,000 yuan per vial, and the specific use of the drug is subject to medical advice. This drug belongs to the vascular endothelial growth factor inhibitors, suitable for the treatment of recurrent glioblastoma, hepatocellular carcinoma, metastatic colorectal cancer, advanced recurrent or metastatic non-small-cell lung cancer, fallopian tube carcinoma, epithelial ovarian cancer, or primary peritoneal carcinoma and other types of malignant tumors. The price of the drug in 2022 probably ranges from 1,450 to 2,000 yuan/vial (specification 100mg:4mg), the reason for the difference mainly stems from the different sales channels and sales regions, while the specific price should refer to the local pharmacy or hospital. Contraindications include hypersensitivity to the product, adverse drug reactions include leukopenia and thrombocytopenia, febrile neutropenia, hypertension, peripheral sensory neuropathy, nausea, vomiting, diarrhea, abdominal pain and so on. Specific medication should be under the guidance of a specialist, not unauthorized use of medication.